Removing Incentives To Lower Drug Prices Isn’t Pharma ‘Reform’

Tuesday, January 14th 2025, 12:37:28 pm
article
Delinking legislation is a giveaway to the pharmaceutical industry that will prove costly to taxpayers and Part D enrollees.
Breaking
Taxpayer dollars are now under the spotlight ahead of Saturday’s “No Kings” protests, as mounting scrutiny zeroes in on whether publicly funded organizations are tied to the activism unfolding across ...
Bob Costas supports IOC's ban on trans women athletes, calling it common sense amid heated debate....
loading...